Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Information Update - Health Canada warns about hand sanitizers that may pose health risks


OTTAWA, ON, Dec. 21, 2021 /CNW/ - Health Canada is advising Canadians that the following hand sanitizers are being recalled because they may pose health risks. For more information, including what Canadians should do, visit the online safety alert.

Health Canada maintains this list of hand sanitizers that may pose health risks, so that Canadians can easily identify products they may have purchased and take appropriate action. Canadians are encouraged to check it regularly for updates.

Product

Health Risk

Company

NPN or DIN

Lot Number

Expiry Date

Action Taken

Sani-Derm

May contain unacceptable ingredient, ethyl acetate

Laboratoires Choisy (Kersia Group)

No NPN or DIN on the label

All Lots

  • January 2022
  • February 2022
  • March 2022
  • April 2022

Product recalled by company

Stay connected with Health Canada and receive the latest advisories and product recalls.

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 17:48
Hundreds of Community Leaders Kick Off Multi-city Convening in Bakersfield With a Simple Message: Do Not Cut San Joaquin Valley Programs & Services
On Wednesday, April 17, the San Joaquin Valley Health Fund (SJVHF) launched "Equity on the Road" a multi-city series of community town halls to deepen local understanding of state issues and to advocate for more resources in the San Joaquin Valley....

at 17:44
NOTICE TO THE MEDIA - Minister Holland to highlight Budget 2024: Fairness for Every Generation investments in students
The Honourable Mark Holland, Minister of Health, will host an event at the University of Waterloo to highlight the federal budget's investments to support students. The Minister will be joined by Bryan May, Parliamentary Secretary to the Minister of...

at 17:31
Global Radioimmunoassay Market to Grow at a Minimal CAGR of ~3% by 2030 | DelveInsight
The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along with a growing number of epidemics and pandemics and increasing health awareness. Moreover,...

at 17:00
Avicanna Announces Closing of Non-brokered Private Placement
Avicanna Inc. ("Avicanna" or the "Company") a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that it has closed a non-brokered private...

at 16:46
Darling Ingredients Inc. to Release First Quarter 2024 Financial Results
Darling Ingredients Inc. announced today that it will host a conference call on Thursday, April 25, 2024, at 9 a.m. Eastern Time (8 a.m. Central Time) to discuss first quarter 2024 financial results, which will be released earlier that day, and...

at 16:45
FDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Alecensa® (alectinib) for adjuvant treatment following tumor resection for patients with anaplastic...

More news about Health...


News published on and distributed by: